', 'auto', 'clientTracker'); ga('clientTracker.send', 'pageview');
Jan 20, 2020
Dr. Bryan McLaughlin is the president of Micro-Leads, a medical device company working on implantable therapy for spinal cord stimulation. In this episode, he discusses his research and investigation into medical-grade technologies to treat spinal cord injury, as well as his collaboration with DARPA in this endeavor.
Top three takeaways:
[0:00] Ladan introduces the episode and the guest, Dr. Bryan McLaughlin, at SfN 2019
[1:15] Micro-Leads distinguishes itself from other spinal cord stimulation companies by offering electrodes that reach fibers that couldn’t have been targeted previously, with more electrode channels
[4:45] This technology specifically targets pain, which is a major unmet need
[6:15] Dr. McLaughlin’s research company has devised medical-grade electrode technology using soft, flexible materials that can be used to help patients with spinal cord injury.
[8:50] Dr. McLaughlin discusses collaborating with DARPA to develop technologies for treating spinal cord injury